Identification of a dual FLT3 and MNK2 inhibitor for acute myeloid leukemia treatment using a structure-based virtual screening approach
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a dual FLT3 and MNK2 inhibitor for acute myeloid leukemia treatment using a structure-based virtual screening approach
Authors
Keywords
FLT3 inhibitors, MNK2 inhibitors, Dual inhibitors, Acute myeloid leukemia, Structure-based virtual screening
Journal
BIOORGANIC CHEMISTRY
Volume 121, Issue -, Pages 105675
Publisher
Elsevier BV
Online
2022-02-11
DOI
10.1016/j.bioorg.2022.105675
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Investigation of Selected Flavonoid Derivatives as Potent FLT3 Inhibitors for the Potential Treatment of Acute Myeloid Leukemia
- (2021) Shih-Chung Yen et al. JOURNAL OF NATURAL PRODUCTS
- Aromatic Rings as Molecular Determinants for the Molecular Recognition of Protein Kinase Inhibitors
- (2021) Yan Zhu et al. MOLECULES
- Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer
- (2020) Celia Pinto-Díez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Small-Molecule Fms-like Tyrosine Kinase 3 Inhibitors: An Attractive and Efficient Method for the Treatment of Acute Myeloid Leukemia
- (2020) Yue Zhong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biological Evaluation of Selected Flavonoids as Inhibitors of MNKs Targeting Acute Myeloid Leukemia
- (2020) Liang-Chieh Chen et al. JOURNAL OF NATURAL PRODUCTS
- Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities
- (2020) Xin Zhao et al. SEMINARS IN CANCER BIOLOGY
- The MAP kinase-interacting kinases (MNKs) as targets in oncology
- (2019) Jianling Xie et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Clonal selection with Ras pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia
- (2019) Christine M. McMahon et al. Cancer Discovery
- Incidence and risk of hematologic toxicities with hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukopenia
- (2018) Chong Gao et al. MEDICINE
- Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia
- (2017) Sarah Diab et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An update of current treatments for adult acute myeloid leukemia
- (2015) H. Dombret et al. BLOOD
- Targeting Mnks for Cancer Therapy
- (2015) Jinqiang Hou et al. Oncotarget
- Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy
- (2014) Alexander A Warkentin et al. eLife
- Navigating the kinome
- (2011) James T Metz et al. Nature Chemical Biology
- Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development
- (2010) T. Ueda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin
- (2009) S. Assouline et al. BLOOD
- Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
- (2009) S. Park et al. HAEMATOLOGICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started